This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The Salk Institute. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Reyna Hernandez-Benitez: Innovator in Genome Editing
Introduction
Reyna Hernandez-Benitez is a prominent inventor based in La Jolla, CA (US). She has made significant contributions to the field of genome editing, particularly in non-dividing cells. With a total of 2 patents, her work is paving the way for advancements in genetic engineering.
Latest Patents
Hernandez-Benitez's latest patents focus on methods and compositions for genome editing in non-dividing cells. These patents disclose homology-independent targeted integration methods that allow for the integration of an exogenous DNA sequence into the genome of a non-dividing cell. The methods involve contacting the non-dividing cell with a composition that includes a targeting construct comprising the exogenous DNA sequence and a targeting sequence, a complementary strand oligonucleotide homologous to the targeting sequence, and a nuclease. This innovative approach alters the genome of the non-dividing cell, showcasing her expertise in genetic manipulation.
Career Highlights
Reyna Hernandez-Benitez is affiliated with the Salk Institute, where she conducts her research. Her work has garnered attention for its potential applications in various fields, including medicine and biotechnology.
Collaborations
Hernandez-Benitez collaborates with notable scientists such as Yuji Tsunekawa and Juan Carlos Izpisua Belmonte. These collaborations enhance her research and contribute to the advancement of genome editing technologies.
Conclusion
Reyna Hernandez-Benitez is a trailblazer in the field of genome editing, with her innovative methods and compositions significantly impacting genetic research. Her contributions are essential for the future of genetic engineering and biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
